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ABSTRACT 
In the present study an attempt is made to assess the pattern of drug use among pregnant women and to evaluate the impact of counseling on 
medication adherence by providing patient education regarding pregnancy. During the study period pregnant women were enrolled in the 
study  after  obtaining  consent  from  them.  The  prescriptions  containing  atleast  one  drug  were  analyzed  and  the  drugs  prescribed  were 
classified according to their pharmacological class. Analysis of prescription patterns did not show the use of any drugs that should not be 
prescribed during pregnancy. Majority of the drugs prescribed belonged to vitamins, minerals and nutrients which play a very major role in 
foetal development. During the study, medication adherence of the pregnant women was assessed and the impact of counseling on adherence 
was seen. There is an increase in the rate of adherence in the pregnant women during their first and second follow-ups when compared with 
their baseline medication adherence. Pregnant women should be counseled and educated regarding the advantages and disadvantages of 
various drug used during pregnancy. The impact of self-medication and other alternative therapies should also be explained to them. 
Key Words: Prescription pattern analysis, Medication adherence, Patient education. 
 
INTRODUCTION 
The  study  of  prescribing  pattern  is  a  component  of 
medical  audit  which  seeks  monitoring,  evaluation  and 
necessary  modifications  in  the  prescribing  practices  of 
the  prescribers  to  achieve  rational  and  cost  effective 
medical  care.  Thus  the  monitoring  of  prescription  and 
drug  utilization  studies  can  identify  the  problems  and 
provide feedback to prescribers so as to create awareness 
about irrational use of drugs
1. 
Rational  drug  prescribing  is  defined  as  the  use  of  the 
least number of drugs to obtain the best possible effect in 
the shortest period and at a reasonable cost
2.Prescribing 
drugs  during  pregnancy  presents  a  challenge  to  the 
physician to balance optimal treatment of the maternal 
symptoms  and  disease  against  possible  harm  to  the 
foetus.  For  many  drugs  including  those  recently 
marketed, data are still inadequate to confirm their safety 
during pregnancy
3. 
A review of drug use during pregnancy  has  suggested 
that more than 80% of pregnant women take atleast one 
type  of  medication  during  pregnancy.  Disregarding 
vitamin  and  iron  supplementation,  analgesics/ 
antipyretics, anti-infectives and anti-histamines account 
for the majority of drugs consumed during pregnancy
4. 
In pregnancy, drug treatment presents a special concern 
due to the threat of potential teratogenic effects of the 
drug  and  physiologic  adjustments  in  the  mother,  in 
response  to  pregnancy
5.  The  safe  use  of  drugs  during 
pregnancy  is  essential  to  optimize  the  health  of  both 
pregnant  women  and  their  foetuses
6.  Careful 
consideration of the benefit to the mother and the risk to 
the  foetus  is  required  while  prescribing  drugs  during 
pregnancy. The use of drugs during pregnancy calls for 
special attention because in this case in addition to the 
mother, the health and life of her unborn child is also at 
stake.  The  drugs  given  to  pregnant  mothers  for 
therapeutic  purposes  may  cause  serious  structural  and 
functional adverse effects in the developing child. Since 
it is very difficult to determine the effects on the foetus 
before  marketing  new  drugs  due  to  obvious  ethical 
reasons,  most  drugs  are  not  recommended  to  be  used 
during  pregnancy.  Since  there  are  numerous  gaps  in 
knowledge  about  deleterious  consequences  for  the 
foetus, prescription drug use by pregnant women should 
be  viewed  as  a  public  health  issue
7.The  use  of  drugs 
during pregnancy requires maintenance of a fine balance. 
Before prescribing a drug, consideration must be given to 
any potentially harmful effects on the foetus. Equally, no 
harm must come to the mother or baby because a disease 
is  being  inadequately  treated.  To  minimize  the  foetal 
risks, the lowest possible effective dose should be used. 
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to  teratogenic  drugs,  there  are  risks  associated  with 
misinformation  about  the  teratogenicity  of  drugs.  This 
can  lead  to  unnecessary  abortions  or the  avoidance  of 
essential treatment. The drug manufacturers and medical 
community should make every effort possible to protect 
women and their unborn babies from both risks. Implicit 
in this statement is the need to counsel pregnant women 
about the safety as well as the dangers of drug use in 
pregnancy
8. 
Adherence  may  be  defined  as  the  extent  to  which  a 
patient’s  behavior  (in  terms  of  taking  medication, 
following a diet, modifying habits, or attending clinics) 
coincides  with  medical  or  health  advice
9.  Some 
investigators  have  further  refined  the  definition  of 
adherence  to  include  data  on  dose  taking  (taking  the 
prescribed number of pills each day) and the timing of 
doses  (taking  pills  within  a  prescribed  period). 
Adherence rates are typically higher among patients with 
acute conditions, as compared with those with chronic 
conditions;  persistence  among  patients  with  chronic 
conditions  is  disappointingly  low,  dropping  most 
dramatically after the first six months of therapy
10. Lack 
of  adherence  may  result  from  patient-related  factors, 
such as a lack of motivation, or from effects from the 
medication,  such  as  side  effects,  but  it  may  also  be 
related  to  the  provider
11.  If  the  goal  of  medication 
adherence  is  to  improve  the  outcome  for  each  patient 
through  the  correct  use  of  prescribed  medicines,  then 
what is ultimately needed is a multidisciplinary approach 
to  adherence  management  whereby  the  patient  and  all 
members of the health care team work together to cure 
the patient’s illness, provide symptom relief, or arrest the 
disease process
12. Physicians counseling women who are 
pregnant or are planning a pregnancy should make sure 
that they understand clearly the nature and magnitude of 
a risk associated with a drug
13. 
In  the  present  study  an  attempt  is  made  to  assess  the 
pattern  of  drug  use  among  pregnant  women  and  to 
evaluate  the  impact  of  counseling  on  medication 
adherence  by  providing  patient  education  regarding 
pregnancy. 
OBJECTIVES 
Ø To  study  the  prescribing  patterns  of  drugs  during 
pregnancy  in  the  department  of  Obstetrics  and 
Gynecology. 
Ø To educate the pregnant women regarding drugs and 
diet during pregnancy. 
Ø To  evaluate  the  medication  adherence  of  drug  use 
during pregnancy.  
 
 
 
MATERIALS AND METHODS 
Study Site 
The study was conducted in the outpatient department of 
Obstetrics  and  Gynaecology,  at  HKES  Basaveshwar 
teaching  and  general  hospital,  Sedam  road,  Gulbarga, 
which is 750 bed tertiary care hospital. 
Study duration Study has been carried out for a period 
of nine months from May 2010 to February 2011. 
Study design  It was a prospective study conducted on 
100  pregnant  women  to  know the  prescribing  patterns 
and  impact  of  counselling  on  medication  adherence 
during pregnancy. 
Study criteria Pregnant women were enrolled into the 
study by considering the following criteria: 
Inclusion Criteria 
Ø Pregnant women attending to the OBG-OPD who are 
on atleast  one drug treatment were enrolled  in the 
study including atleast 2 follow ups. 
Ø Pregnant women who are willing to participate in the 
study.  
Ø Pregnant women of age above 18years. 
Exclusion Criteria 
Ø Pregnant women below the age of 18 years. 
Ø Pregnant women who are not willing to participate in 
the study. 
Source of data 
Ø Pregnant women visiting Obstetrics and Gynaecology 
Outpatient    Department  of  HKES’s  Basaveshwar 
Teaching and General Hospital, Gulbarga. 
Ø Data collection forms and outpatient cards of above 
pregnant women. 
Study procedure 
The data relevant to the study was collected from 115 
pregnant women but only 100 were enrolled in the study 
as fifteen pregnant women did not turn up for follow ups 
for unknown reasons. 
Prescribing pattern analysis 
Prescriptions of the pregnant women containing atleast 
one drug were analyzed and the drugs prescribed were 
classified according to their pharmacological class. The 
pregnant  women  were  divided  according  to  their 
trimester  and  the  prescriptions  were  analyzed  for 
different classes of drugs. 
Assessment of Medication Adherence 
The medication adherence of the pregnant women was 
assessed  at  baseline  line  by  using  the  medication 
adherence  questionnaires.  Then  the  pregnant  women 
were  counseled  regarding  drug  use  and  importance  of 
medication  adherence. During  first and second  follow-
ups same medication adherence questionnaires were used 
to reassess their medication adherence.   
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Statistical analysis 
Statistical analysis of the data was done by chi square 
method and Wilcoxon signed- ranked test. 
RESULTS 
During the 6 month study period, 115 pregnant women 
were enrolled.  Total 100 pregnant women completed the 
study; the remaining fifteen pregnant women did not turn 
for the follow up due to unknown reasons. Those who 
have completed the study were included in the analysis. 
Baseline  demographic  characteristics  of  enrolled 
pregnant women 
Age 
The age distribution of enrolled pregnant women  is as 
follows 29(29%) of pregnant women were between the 
age group of 17-21 years of age, 51(51%) were between 
the age group of 22 - 26 years of age, 18 (18%) were 
between  the  age  group  of  27-31  and  2  (2%)  were 
between the age group of 32-36. 
Educational Background 
Among the participants of the study, 41 (41%) of women 
were  having  formal  education  and  were  graduates,59 
(59%)  were  illiterate  who  have  not  received  any 
education because most of the women belongs to rural 
area. 
Socio-economic status 
The  socio-economic  status  of  the  pregnant  women 
enrolled in the study was also considered. Among 100 
women 41 (41%) were poor and the remaining 59 (59%) 
women were from middle class families. 
Region 
Among 100 pregnant women enrolled in the study, 69 
(69%) were from urban area and 31 (31%) women were 
from rural areas. 
Trimester wise classification 
Among  100  women  enrolled  in  the  study,  35  (35%) 
women were from first trimester, 61 (61%) women were 
from second trimester and the remaining 4 (4%) are form 
third trimester. 
Co-morbidities 
Among 100 pregnant women enrolled in the study, 28 
(28%)  were  known  to  have  anaemia,  12  (12%)  were 
having  hypertension  and  2  women  were  having  both 
anaemia and hypertension. 
Number of children 
Among  100  pregnant  women  enrolled  in  the  study  19 
(19%) women were not having any children, 40 (40%) 
women had one child, 32 (32%) women were having two 
children and  (9%) women were having three and more 
children. 
 
 
 
Prescribing pattern analysis of pregnant women 
Drug Use during First Trimester 
The study was done by enrolling 100 pregnant women 
among  whom  35  of  them  belonged  to  first  trimester. 
Among the 35 women 26 (74%) of them were prescribed 
with folic acid, vitamins were prescribed for 5 (14.2%) 
women, proteins for 17 (48.5%) women, nutrients were 
prescribed  for  5  (14.2%)  women,  iron,  calcium  were 
prescribed for 1 (2.8%) woman and 1 (2.8%) woman was 
prescribed with other (anti-cold) drug and none of them 
were prescribed with anti-hypertensives. The results are 
shown in Table 1 
Drug use during second trimester 
Among  100  pregnant  women  enrolled,  61  women 
belonged to second trimester out of which 20 (32.7%) 
were prescribed with folic acid, vitamins were prescribed 
to 35 (57.3%) pregnant women, proteins to 38 (62.2%), 
nutrients to 15 (24.5%) women, anti-hypertensives to 10 
(16.3%)  women,  iron  was  prescribed  to  24  (39.35%) 
women and calcium to 41 (67.2%) women. None of them 
were prescribed with other classes of drugs. The results 
are shown in Table 2. 
Drug use during third trimester 
Among the 100 pregnant women in whom the study was 
conducted,  4  of  them  belonged  to  third  trimester  of 
which 2 (50%) women were prescribed with folic acid, 
proteins were prescribed to 3 (75%) women, 2 (50%) of 
them  were  prescribed  with  anti-hypertensives  and  iron 
supplements, all the 4 (100%) women were prescribed 
with  calcium  and  none  of  them  were  prescribed  with 
vitamins, nutrients and any other classes of drugs. The 
results are shown in Table 3. 
Assessment of medication adherence in pregnant 
women 
Morisky Medication Adherence Scale (MAS) Score 
All  the  100  participants  of  the  study  were  initially 
provided MAS questionnaires at the time of enrollment 
and  subsequent  follow  up  and  medication  adherence 
score was evaluated at baseline, first and second follow 
up.  
Baseline to first follow up showed a mean increase in 
medication adherence level of 1.340 ± 0.2184 and (P < 
0.0001) which is statistically significant. 
Baseline to second follow up showed a mean increase of 
2.490 ± 0.1930 and (P < 0.0001) which is statistically 
significant. The results are shown in Table 4.1 and 4.2. 
Improvement of medication adherence by comparing 
literacy rate of pregnant women: 
Overall medication adherence of pregnant women based 
on  the  literacy  rate  was  compared  by  using  Wilcoxon 
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Medication Adherence Scores in literate pregnant 
women. 
Baseline score to first follow up score in literate pregnant 
women  revealed  a  mean  increase  in  medication 
adherence level of 1.271 ± 0.2914 with P<0.0001 which 
is statistically significant. 
Baseline to second follow up showed a mean increase of 
2.542 ± 0.2314 with P<0.0001 which is significant. The 
results are explained in Table 5.1 and 5.2. 
Medication Adherence Scores in illiterate pregnant 
women. 
Baseline  score  to  first  follow  up  score  in  illiterate 
pregnant women revealed a mean increase in medication 
adherence level of 1.512 ± 0.3096 with P<0.0001 which 
is statistically significant. 
Baseline to second follow up show a mean increase of 
2.439 ± 0.3056 with P<0.0001 which is significant. The 
results are shown in Table 6.1 and 6.2 
DISCUSSION 
Prescriptions of the pregnant women were analyzed for 
different classes of drugs prescribed during pregnancy. 
Folic acid was prescribed to 26 (74.2%) women in their 
first trimester, 20 (32.7%) in second trimester, to 2 (2%) 
women in their third trimester. Vitamins were prescribed 
to 5 (14.2%) pregnant women in first trimester and to 35 
(37.3%) women  in  second trimester and  none of them 
were prescribed with vitamins in third trimester. Proteins 
were prescribed to 17 (48.5%), 38 (62.2%) and 3 (75%) 
pregnant women in their first, second and third trimesters 
respectively.Nutrients  were  prescribed  to  5  (14.2%)  in 
first trimester and to 15 (15%) in second trimester. Anti-
hypertensive drugs were not prescribed to any pregnant 
women  belonging  to  first  trimester  and  to  10  (16.3%) 
during second trimester and to 2 (50%) women in their 
third trimester. Iron was prescribed to 1 (2.8%) woman 
in first trimester, 24 (39.3%) during second trimester and 
to 2 (50%) women during third trimester. Calcium was 
prescribed to 1 (2.8%) woman  in  first trimester, to 41 
(67.2%) women during their second trimester and to 4 
(100%) women in third trimester. Other classes of drugs 
were prescribed in 1 (2.8%) woman.  
A  similar  study  was  conducted  by  Dileep  K  Rohra  in 
which anti-anemic drugs including iron preparations and 
vitamin and mineral supplements (79.4%) were the most 
frequently  prescribed  drugs  followed  by  analgesics 
(6.2%)  and  anti-bacterials  (2.2%).  Seven  thirty  nine 
women (19.6%) received prescriptions containing drugs 
other than vitamin or mineral supplements
7. 
During the study medication adherence of the pregnant 
women was assessed and the  impact of counseling on 
adherence was seen. There is an increase in the rate of 
adherence in the pregnant women during their first and 
second  follow-ups  when  compared  with  their  baseline 
medication  adherence  scores.  The  study  showed 
significant  difference  in  medication  adherence  at 
baseline to first and second follow ups (P<0.0001). The 
medication  adherence  scores  during  first,  second  and 
third trimesters were also significant at baseline level to 
first and second follow ups.  
During  the  time  of  baseline  assessment  we  asked  the 
reasons  to  stop/miss  the  medications  to  the  patients. 
Following were the reasons: (Results are shown in table 
7). 
Fifty nine (59%) pregnant women reported thathigh cost 
of the medication was one of the reasons for medication 
non-adherence.  As  majority  of  the  pregnant  women 
enrolled were from poor and middle class families and 
from low economic group they couldn’t afford the cost 
of medications.  
Another  frequently  reported  reason  for  non-adherence 
was forgetfulness 64(64%). This problem was resolved 
by  using  the  tools  like  medication  reminder  or  diary 
keeping.  
Twenty six (26%) pregnant women reported that lack of 
access to hospital or drug store was another main reason 
for  prescription  non-adherence.  Many  of  the  pregnant 
women  were  from  rural  areas  where  they  don’t  have 
access to health care services, or medications.   
Twenty three (23%) women reported that fear of side 
effects  caused  by  the  medications  was  the  problem  to 
continue  their  therapy.  This  problem  was  solved  by 
counseling them regarding  side effects caused  by each 
drug and rescue action to be taken when it happens.  
Thirteen  (13%)  pregnant  women  believed  that  the 
medications  were  not  very  effective,  9  (9%)  of  them 
were having occupational problems and 6 (6%) women 
were non-adherent due to lack of motivation and family 
support.  All  the  reasons  for  medication  non-adherence 
were  solved  by  providing  counseling  by  clinical 
pharmacist  in  specific  areas  so  as  to  improve  their 
adherence rates.  
CONCLUSION 
Analysis of prescription patterns did not show the use of 
any  drugs  that  should  not  be  prescribed  during 
pregnancy. Majority of the drugs prescribed belonged to 
vitamins, minerals and nutrients which play a very major 
role  in  foetal  development.  Other  drugs  mostly 
prescribed  were  anti-hypertensives  which  were 
prescribed in pre-eclampsia patients. Anti-hypertensives 
which  are  contraindicated  in  pregnancy  were  not 
prescribed to any patients. 
In the study the major reasons for non-adherence were 
forgetfulness, cost of medications, lack of hospital/drug 
store, fear of side effects and lack of motivation. Patient Banda Shalini Reddy et al. IRJP 2 (8) 2011 148-153 
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education  and  counselling  may  be  effective  in  solving 
some of the problems, except lack of hospital/drug store 
and  high  cost  of  medications  which  need  further 
strategies to improve them. By providing counseling and 
patient education, the rate of medication adherence was 
improved  during  first  and  second  follow-ups  when 
compared with the baseline assessment. 
Pregnant  women  should  be  counseled  and  educated 
regarding  the  advantages  and  disadvantages  of  various 
drug  used  during  pregnancy.  The  impact  of  self-
medication and other alternative therapies should also be 
explained to them. 
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Table 1: Pattern of drug use in first trimester 
PHARMACOLOGICAL CLASS  NO.OF PREGNANT WOMEN 
FOLIC  ACID 
VITAMINS 
PROTEINS 
NUTRIENTS 
ANTI-HYPERTENSIVES 
IRON 
CALCIUM 
OTHERS 
26 (74.2%) 
5 (14.2%) 
17 (48.5%) 
5 (14.2%) 
0 
1 (2.8%) 
1 (2.8%) 
1 (2.8%) 
 
Table 2: Pattern of drug use in second trimester 
PHARMACOLOGICAL CLASS  NO.OF PREGNANT WOMEN 
FOLIC  ACID 
VITAMINS 
PROTEINS 
NUTRIENTS 
ANTI-HYPERTENSIVES 
IRON 
CALCIUM 
OTHERS 
20 (32.7%) 
35 (57.3%) 
38 (62.2%) 
15 (24.5%) 
10 (16.3%) 
24 (39.3%) 
41 (67.2%) 
00 
 
Table 3: Pattern of drug use in third trimester 
PHARMACOLOGICAL CLASS  NO.OF PREGNANT WOMEN 
FOLIC  ACID 
VITAMINS 
PROTEINS 
NUTRIENTS 
ANTI-HYPERTENSIVES 
IRON 
CALCIUM 
OTHERS 
02 (50%) 
00 
03 (75%) 
00 
02 (50%) 
02 (50%) 
04 (100%) 
00 
 
Morisky Medication Adherence Score (MAS) (n=100): Score (0-6) 
 
Table 4.1: Baseline adherence score to first follow up score 
Average of 
Baseline 
Average of Follow 
up I 
Mean ± 
SD 
P-Value 
2.47  3.81  1.340 ± 
0.2184 
P<0.0001 
 
Table 4.2: Baseline adherence score to second follow up score 
Average of 
Baseline 
Average of Follow 
up II 
Mean ± SD  P-Value 
2.47  4.96  2.490 ± 
0.1930 
P<0.0001 
 
Medication Adherence Score in literate pregnant women (n=59): Score(0-6) 
 
Table 5.1: Baseline adherence score to first follow up score 
Average of 
Baseline 
Average of 
Follow up I 
Mean ± SD  P-Value 
2.76  4.03  1.271 ± 
0.2914 
P<0.0001 
 
Table 5.2: Baseline adherence score to second follow up score 
Average 
of 
Baseline 
Average of 
Follow up II 
Mean ± SD  P-Value 
2.76  5.30  2.542 ± 
0.2314 
P<0.0001 
 
Medication Adherence Score in illiterate pregnant women(n=41):Score(0-6) 
Table 6.1: Baseline adherence score to first follow up score 
Average of 
Baseline 
Average of 
Follow up I 
Mean ± SD  P-Value 
2.02  3.53  1.512 ± 
0.3096 
P<0.0001 
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Table 6.2: Baseline adherence score to second follow up score 
Average of Baseline  Average of Follow up 
II 
Mean ± SD  P-Value 
2.02  4.46  2.439 ± 0.3056  P<0.0001 
 
Table 7: Factors for medication non-adherence: 
 
Reasons  No. Of Patients 
(n=100) 
Percentage 
(%) 
Forgetfulness  64  64 
High cost of medications  59  59 
Lack of access to hospital/drug store  26  26 
Fear of side effects  23  23 
Believed medication was not 
effective and decided not to take 
dose 
13  13 
Absorbed in daily work and forget to 
take/Occupation related problems 
09  09 
Lack of family support/Motivation  06  06 
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